Clinical Trials Directory

Trials / Unknown

UnknownNCT06102343

Safety and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER:Glass 1540nm Laser Module in the Treatment of Acne Scars.

Open-label, Safety, and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER: Glass 1540nm Laser Module in the Treatment of Acne Scars.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
41 (estimated)
Sponsor
Alma Lasers · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The ClearSkin module, Er: Glass 1540nm, is largely used in the treatment of acne vulgaris and acne scars. The non-ablative ER:Glass 1540 nm laser deeply penetrates the skin, causing thermal damage to the sebaceous glands, destroying P. acnes bacteria and reducing sebum production, while leaving the epidermis intact. The integrated vacuum mechanism extracts accumulated sebaceous material from the pores, while contact cooling protects the skin, reducing pain and allowing for safer and more effective treatment of the sebaceous glands within the dermis. Based on this background, the investigators have considered a pilot study aimed at assessing the efficacy and safety of the ClearSkin Module in treating subjects with facial acne scars.

Conditions

Interventions

TypeNameDescription
DEVICEAlma HarmonyAcne scars treatment using non-ablative ER:Glass 1540 nm laser module.

Timeline

Start date
2024-01-01
Primary completion
2025-01-01
Completion
2025-01-01
First posted
2023-10-26
Last updated
2023-10-26

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT06102343. Inclusion in this directory is not an endorsement.